At a glance
- Originator Sankyo
- Class Antibacterials
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 15 Jul 1997 New profile
- 15 Jul 1997 Preclinical development for Bacterial infections in Japan (Transurethral)